ODDB.org: Open Drug Database

Azithromycin-Mepha 200, Pulver zur Herstellung einer Suspension zum Einnehmen - 30 ml

Swissmedic Key	58081003	Registration Holder	Mepha Pharma AG
Name	Azithromycin-Mepha 200, Pulver zur Herstellung einer Suspension zum Einnehmen	Date of registration	25.07.2007
Original/Generic	Generic	Introduction of Sequence	25.07.2007
ATC-Classification	Azithromycin (J01FA10)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	08.01.60.	Show package size	30 ml
Index Therapeuticus (Swissmedic)	08.01.60.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	8.93	Limitation	No

Deductible	10 %	Consumer price	26.10
Feedback	FB	Daily cost
GTIN	7680580810034	Medication Code	Synthetika
Pharmacode	3636069	Disponibility

Composition

azithromycinum 200 mg ut azithromycinum dihydricum, saccharum 3712 mg, xanthani gummi, hydroxypropylcellulosum, trinatrii phosphas anhydricus, silica colloidalis anhydrica, aromatica (Vanille, Banane, Kirschen) cum alcohol benzylicus, aspartamum 30 mg, excipiens ad pulverem corresp. suspensio reconstituta 5 ml corresp. natrium 7.744 mg, natrium 7.74 mg.

Packungsbestandteile

Galenic Form

Pulver zur Herstellung einer Suspension zum Einnehmen

Excipiens

Active Agent	Dose
Azithromycin	200 mg

BAG: Active Agent	Dose
Azithromycin	200 mg

Inactive agents	Dose
Aromatica (Vanille, Banane, Kirschen) cum Alcohol Benzylicus
Aspartame	30 mg
Hydroxypropylcellulosum
Saccharum	3712 mg
Silica Colloidalis Anhydrica
Trinatrii Phosphas Anhydricus
Xanthani Gummi

Source

Data was imported : 07.03.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH